Weixiang Yang

Weixiang Yang

Auto-generated profile, based on publicly available information

Weixiang Yang

Department of Urology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan Hospital, Kunming, 650118, Yunnan, People's Republic of China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2026 in Discover Oncology
Verified
Journal Article
Open access
BXBenmo Xu
Benmo Xu
CLChengbin Lu
Chengbin Lu
SYSinan Yang
Sinan Yang
WYWeixiang Yang
Weixiang Yang
HLHanbin Li
Hanbin Li
YYYong Yang
Yong Yang
A 58-year-old female patient with recurrent left adrenal cortical carcinoma following surgery developed severe nausea, vomiting, anorexia, and hypovolemic shock, accompanied by profound hyponatremia, approximately 2 weeks after receiving pembrolizumab immunotherapy. She was diagnosed with an acute adrenal crisis. The patient had a prior history of mitotane therapy and radiotherapy. It was believed that the adrenal crisis was triggered by pembrolizumab-induced immune-mediated adrenalitis, compounded by cumulative damage to adrenal function from both the treatment and the tumor. After aggressive management, including anti-shock treatment, high-dose glucocorticoid replacement, and symptomatic supportive care, the patient's condition improved. At the 1-month follow-up after discharge, the patient had fully recovered, with normalized hormone levels and no evidence of tumor progression. This case highlights the potential for immune checkpoint inhibitor therapy to induce life-threatening adrenal crises in patients with pre-existing adrenal insufficiency. Clinicians must remain highly vigilant, performing early hormone level screening, promptly initiating hormone replacement therapy, and ensuring multidisciplinary team (MDT) collaboration to improve patient outcomes.

31 January 2026 in Asian Journal of Surgery
Verified
Journal Article
Open access
WDWenchao Ding
Wenchao Ding
SZSonglin Zhu
Songlin Zhu
WYWeixiang Yang
Weixiang Yang
HFHongrui Fu
Hongrui Fu

21 November 2025 in Asian Journal of Surgery
Verified
Journal Article
Open access
CLChengbin Lu
Chengbin Lu
BXBenmo Xu
Benmo Xu
WYWeixiang Yang
Weixiang Yang
HFHongrui Fu
Hongrui Fu

2 February 2026 in Asian Journal of Surgery
Verified
Journal Article
Open access
WDWenchao Ding
Wenchao Ding
BXBenmo Xu
Benmo Xu
WYWeixiang Yang
Weixiang Yang
HFHongrui Fu
Hongrui Fu

31 January 2026 in Asian Journal of Surgery
Verified
Journal Article
Open access
SZSonglin Zhu
Songlin Zhu
WYWeixiang Yang
Weixiang Yang
WDWenchao Ding
Wenchao Ding
HFHongrui Fu
Hongrui Fu